1. Home
  2. RVP vs LTRN Comparison

RVP vs LTRN Comparison

Compare RVP & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Retractable Technologies Inc.

RVP

Retractable Technologies Inc.

HOLD

Current Price

$0.63

Market Cap

18.9M

Sector

Health Care

ML Signal

HOLD

Logo Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

HOLD

Current Price

$2.18

Market Cap

22.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVP
LTRN
Founded
1994
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.9M
22.2M
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
RVP
LTRN
Price
$0.63
$2.18
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
44.8K
1.2M
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.65
EPS
N/A
N/A
Revenue
$38,266,211.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
15.78
N/A
52 Week Low
$0.60
$1.11
52 Week High
$1.14
$5.74

Technical Indicators

Market Signals
Indicator
RVP
LTRN
Relative Strength Index (RSI) 40.10 48.38
Support Level $0.62 $1.11
Resistance Level $0.73 $2.41
Average True Range (ATR) 0.04 0.30
MACD -0.00 0.03
Stochastic Oscillator 22.99 40.21

Price Performance

Historical Comparison
RVP
LTRN

About RVP Retractable Technologies Inc.

Retractable Technologies Inc is engaged in the manufacturing and marketing of safety medical products (predominantly syringes) for the healthcare industry. It has manufacturing facilities in Little Elm, Texas, and uses manufacturers in China as well. Its syringes are well-suited for administering vaccinations. The company's products are VanishPoint Syringe, VanishPoint Insulin Syringes, EasyPoint Needle, EasyPoint Blood Collection Tube with Needle, VanishPoint Blood Collection Set, and VanishPoint IV Catheter. It provides solutions such as Insulin, Immunization, Blood Collection, Allergy, General Purpose, and Infusion.

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

Share on Social Networks: